Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays. - Wikidata - awgldk - TriplyDB

Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays.

Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays.

http://www.wikidata.org/entity/Q40711453

about

Perspective: Adhesion Mediated Signal Transduction in Bacterial Pathogens Design of O -Acetylserine Sulfhydrylase Inhibitors by Mimicking Nature Transcriptional profiling of serogroup B Neisseria meningitidis growing in human blood: an approach to vaccine antigen discovery Stem-loop structures in prokaryotic genomes NERVE: new enhanced reverse vaccinology environment Evaluation of reference genes for real-time RT-PCR expression studies in the plant pathogen Pectobacterium atrosepticum The pleiotropic CymR regulator of Staphylococcus aureus plays an important role in virulence and stress response Review of meningococcal group B vaccines.Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates.Transcriptional responses of Leptospira interrogans to host innate immunity: significant changes in metabolism, oxygen tolerance, and outer membrane The role of glyceraldehyde 3-phosphate dehydrogenase (GapA-1) in Neisseria meningitidis adherence to human cells.CrgA is an inducible LysR-type regulator of Neisseria meningitidis, acting both as a repressor and as an activator of gene transcription.Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival.NafA negatively controls Neisseria meningitidis piliation.Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.Identification of immunogenic and serum binding proteins of Staphylococcus epidermidis.Approaches to bacterial RNA isolation and purification for microarray analysis of Escherichia coli K1 interaction with human brain microvascular endothelial cells.Genome wide expression profiling reveals suppression of host defence responses during colonisation by Neisseria meningitides but not N. lactamica.Metabolism and virulence in Neisseria meningitidis.Burkholderia pseudomallei transcriptional adaptation in macrophages.An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis Cysteine depletion causes oxidative stress and triggers outer membrane vesicle release by Neisseria meningitidis; implications for vaccine development The REP2 repeats of the genome of Neisseria meningitidis are associated with genes coordinately regulated during bacterial cell interaction The environment of "Mycobacterium avium subsp. hominissuis" microaggregates induces synthesis of small proteins associated with efficient infection of respiratory epithelial cells Evaluation of truncated NhhA protein as a candidate meningococcal vaccine antigen.RNA profiling in host-pathogen interactions.Bioinformatics: how it is being used to identify bacterial vaccine candidates.Glycoconjugate vaccines to prevent group B streptococcal infections.Identification of iron-activated and -repressed Fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B.Use of the chinchilla model for nasopharyngeal colonization to study gene expression by Moraxella catarrhalis Identification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in mice.The potential of antibody-mediated immunity in the defence against biological weapons.Towards an improved serogroup B Neisseria meningitidis vaccine.Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870 Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine A comparison of the endotoxin biosynthesis and protein oxidation pathways in the biogenesis of the outer membrane of Escherichia coli and Neisseria meningitidis.Post-genomic vaccine development.Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis.Transcriptional modulation of enterotoxigenic Escherichia coli virulence genes in response to epithelial cell interactions Large screen approaches to identify novel malaria vaccine candidates.

P2860

Q26768433-65194156-E489-41BA-B62D-6812905C3AC2 Q27658287-874D50D8-D7B7-4A76-80B6-B0D2ED0118A7 Q28728122-ED82868A-FF1C-4CF4-85ED-7C2042FDFB58 Q33248812-232A3CAC-0059-4A85-B08B-D05544B208BD Q33250601-B4A128BF-3546-4AA3-AFEA-E74D77B1F990 Q33299946-432809A8-9E33-452A-AC3A-2490E754F4C6 Q33582244-FD84D6F9-E936-42D8-8DC3-F1CA40F964DD Q33646965-8EA29DB5-1A02-4926-9B0C-06772AA94B91 Q33695485-2C80B564-3CA5-4CDF-8054-796629B9DF53 Q33737632-DA8FCCB4-EC49-45D7-8BAC-629E356E6A11 Q33742736-D363ED8D-CF8E-443B-BC1C-2D10234DE503 Q33788408-D4B3B3E7-D9F1-40B8-98DB-E9AF366E544C Q33903848-EB84190D-51F5-4EC6-875E-579BEC2B8123 Q33958083-5A9EFCC5-AA31-45DA-A031-1220EABDAB11 Q34033132-EE989892-8736-49F6-990A-D00AED268FD3 Q34033145-531D6E4C-4CF9-4918-83C7-F24B4889B071 Q34041690-B6F24A4D-DD0B-4227-922B-D26968806BEE Q34058392-163D9368-FBBA-45AC-A595-FA18A9F4D50D Q34068118-745EFB32-31A6-4354-9C3D-ECB9AA458DAC Q34347994-48A1264F-7C0D-4745-85D4-FBC481099C8E Q34492775-B69F2AAD-7A09-49B3-9CF1-0B2E2B582FFA Q34571107-D965E4D5-0BF0-4C5D-8F34-985C8AD80389 Q34891781-0D66F9BE-08B9-46BE-A8A2-DF2ACE078A2A Q34955819-65D6CC4C-95C9-4AC1-9CB4-50CAD6635530 Q34988272-70FF3191-E5D2-4CB9-B89F-60855273BB80 Q35083298-736698E1-DE96-452E-981E-0D89E46249FC Q35194195-555399AE-8AFC-4C8D-90E2-CB933174ACE4 Q35207531-677A6592-A5B4-438F-A519-58012D18ECCC Q35234880-9F549673-7F2A-49F5-ADF5-A44C7E329FD4 Q35805451-7F4DD482-79F9-4772-8031-092C9326AA60 Q36005317-5842D594-F1D9-44A6-9EAA-B34BDAA6EC9E Q36273411-92D0456C-EFCE-4749-814A-E8C79FAE8423 Q36327065-F82BE40C-9C11-4617-83A8-B36E91EA1588 Q36370598-572942E9-E2B7-43FF-BDA8-A085B2DA1561 Q36464572-0298DE8E-6392-4B1B-87C0-02BE503B6143 Q36479175-028CAAE8-C5F6-4B49-BB97-FCA6B7300D70 Q36485259-8263B9EF-1FBE-4D48-BB7B-BD0C46E9C538 Q36491155-2EACA3CA-825E-4962-9DAC-591EB506B0DC Q36506158-60268D4C-E0A2-4657-920C-876EADF91C00 Q36510147-0D4DF88E-E9FA-4E3A-A5D6-CCE44AA6C52D

P2860

Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays.

http://www.wikidata.org/entity/Q40711453

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Previously unrecognized vaccin ...... identified by DNA microarrays.

@en

type

label

Previously unrecognized vaccin ...... identified by DNA microarrays.

@en

prefLabel

Previously unrecognized vaccin ...... identified by DNA microarrays.

@en

P1433

Q40711453-949135AF-3608-4AD2-84E9-F1CFC7C88264

P1476

Q40711453-A23AC2AF-2A17-4829-8F7C-E34F3926F501

P2093

Q40711453-008D173C-0153-41D2-B003-0ED8A1DB6D1D

Q40711453-01F28B1D-AE91-490F-A465-CE6A87465F82

Q40711453-078AC1A9-DC18-4546-8956-C8D3C573BD6C

Q40711453-0CF902EB-76FC-4E55-8FFD-F0D185040626

Q40711453-25B350E6-89FB-445C-88E8-69E54FF73C81

Q40711453-4C048D71-9E51-4B55-8553-ED73E82D02E7

Q40711453-4E7D578D-C8A6-4FAF-BD51-78817832C380

Q40711453-62A48ED6-26F5-4587-BF59-0D156FCC775C

Q40711453-67D30B2D-BAA5-4289-9028-F70956F8CD3C

Q40711453-6EC05C4E-1F90-4EF3-9542-170B39F19A17

P2888

Q40711453-70B8BFBC-D7E5-406F-A452-C83A008F4B7B

P304

Q40711453-EA4D7850-340F-4EAE-B651-3FD15AADECB7

P31

Q40711453-8B2A006B-0669-4454-9E1A-06356BAC64AF

P356

Q40711453-AF2FC87D-E6E6-40EE-9B45-20D07628D73D

P433

Q40711453-586CCBAF-8370-49E7-BF3B-FE3D7B1E694D

P478

Q40711453-0FC3D145-4F2D-4E06-8267-5977F9502B01

P50

Q40711453-31232907-8863-46BE-A1BC-90D8C44739CA

P577

Q40711453-4084753B-50AC-40CF-97BC-4114A5924919

P5875

Q40711453-1BC86B4B-B9AF-49F4-A575-5E6B586A4EFE

P698

Q40711453-C19E94BF-C9F2-4A96-BC11-40A3A99CB665

P356

P1433

Nature Biotechnology

P1476

Previously unrecognized vaccin ...... identified by DNA microarrays.

@en

P2093

Alessandro Muzzi

http://www.w3.org/2001/XMLSchema#string

Brunella Brunelli

http://www.w3.org/2001/XMLSchema#string

Elisabetta Frigimelica

http://www.w3.org/2001/XMLSchema#string

Erika Bartolini

http://www.w3.org/2001/XMLSchema#string

Filippo Randazzo

http://www.w3.org/2001/XMLSchema#string

Giuliano Galli

http://www.w3.org/2001/XMLSchema#string

Giulio Ratti

http://www.w3.org/2001/XMLSchema#string

Guido Grandi

http://www.w3.org/2001/XMLSchema#string

Hervé Tettelin

http://www.w3.org/2001/XMLSchema#string

Joel Berger

http://www.w3.org/2001/XMLSchema#string

P2888

P304

914-921

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NBT728

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11213688

http://www.w3.org/2001/XMLSchema#string

P698

12172557

http://www.w3.org/2001/XMLSchema#string